UnitedHealth Group Incorporated $UNH Shares Sold by Janney Montgomery Scott LLC

Key Points

• Janney Montgomery Scott reduced its UnitedHealth position by 7.8% in the second quarter, selling 20,559 shares and retaining 243,641 shares valued at approximately $101.3 million. Institutional investors and hedge funds collectively own 87.86% of the company.
• Analysts remain broadly optimistic, with UnitedHealth holding a “Moderate Buy” consensus rating and an average price target of $455.92. Recent targets range from $400 to $516.
• UnitedHealth exceeded quarterly earnings expectations, reporting $6.38 in EPS versus a $4.94 estimate, and declared a quarterly dividend of $2.32 per share. However, governance, cybersecurity, legal and AI-driven claims-denial concerns remain significant risks.

Janney Montgomery Scott LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 243,641 shares of the healthcare conglomerate's stock after selling 20,559 shares during the period. Janney Montgomery Scott LLC's holdings in UnitedHealth Group were worth $101,265,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Sarver Vrooman Wealth Advisors purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $25,000. Anfield Capital Management LLC grew its position in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock worth $26,000 after buying an additional 55 shares in the last quarter. Joseph Group Capital Management acquired a new stake in UnitedHealth Group in the fourth quarter valued at $27,000. Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $27,000. Finally, Lifetime Wealth Management P.C. acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $29,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth authorized a dividend, reinforcing shareholder returns and signaling confidence in its financial position. However, the announcement comes amid an ongoing governance lawsuit, which may limit its positive impact. UnitedHealth Group Authorizes Dividend Amid Governance Lawsuit
• Positive Sentiment: Wall Street’s average brokerage recommendation remains favorable, suggesting analysts believe UnitedHealth’s valuation and earnings outlook could support the shares. The bullish view is tempered by the tendency of sell-side recommendations to skew optimistic. Wall Street Bulls Look Optimistic About UnitedHealth
• Neutral Sentiment: The expected guilty plea by Luigi Mangione in the federal case involving the killing of UnitedHealthcare CEO Brian Thompson could bring additional clarity to a high-profile event, but it does not materially change UnitedHealth’s operating outlook. Luigi Mangione Reportedly Set to Plead Guilty
• Negative Sentiment: A shareholder lawsuit alleges UnitedHealth misled investors, failed to address governance and cybersecurity weaknesses, and discontinued an internal Medicare billing audit before the Change Healthcare cyberattack. The claims increase potential legal, regulatory and reputational risks. Investor Suit Says UnitedHealth Ignored Governance and Cybersecurity Gaps
• Negative Sentiment: A derivative lawsuit reportedly says executives knew that patients won roughly 90% of appeals against AI-generated claim denials. The allegation raises concerns about the accuracy of automated utilization management, potential compliance costs and damage to UnitedHealth’s reputation. UNH Patients Win 90% of AI Denial Appeals
• Negative Sentiment: An investor analysis argues that margin recovery is already reflected in UnitedHealth’s valuation, leaving future earnings growth as the next major test. This limits upside if revenue or membership growth disappoints. UnitedHealth Margin Recovery Is Priced In

Analysts Set New Price Targets

Several analysts recently weighed in on UNH shares. Piper Sandler set a $477.00 price objective on UnitedHealth Group in a report on Thursday, July 16th. JPMorgan Chase & Co. lifted their target price on UnitedHealth Group from $466.00 to $516.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 21st. Argus raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $400.00 price target on the stock in a research report on Wednesday, April 22nd. DA Davidson set a $512.00 price objective on shares of UnitedHealth Group in a report on Tuesday, July 21st. Finally, Leerink Partners increased their target price on shares of UnitedHealth Group from $400.00 to $462.00 and gave the stock an "outperform" rating in a report on Wednesday, June 17th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $455.92.

UnitedHealth Group Price Performance

Shares of UNH opened at $395.02 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The company has a market cap of $354.57 billion, a P/E ratio of 25.42, a PEG ratio of 1.40 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The stock has a fifty day moving average price of $415.52 and a 200 day moving average price of $353.65.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company's revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group's payout ratio is currently 59.72%.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 500 shares of the firm's stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total value of $205,000.00. Following the sale, the chief executive officer directly owned 16,497 shares in the company, valued at $6,763,770. This trade represents a 2.94% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source